MYRIAD GENETICS DL-,01 revenue breakdown overview

MYRIAD GENETICS DL-,01 revenue for the last year amounted to 682.41 M EUR, the most of which — 296.99 M EUR — came from its highest performing source at the moment, Hereditary Cancers, the year earlier bringing 285.45 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought MYRIAD GENETICS DL-,01 608.57 M EUR, and the year before that — 552.67 M EUR.